Search results
18 mar 2024 · Studies conducted since the 2013 IDSA guideline 5 have addressed new vaccines and the vaccination of patients receiving new types of cancer therapies. Researchers have continued to investigate the safety, immunogenicity, and optimal timing of vaccinations during cancer treatment.
13 gru 2023 · Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is...
26 lut 2024 · The largest vaccine safety study to date has identified two new, but very rare, side effects associated with covid-19 vaccines—transverse myelitis and acute disseminated encephalomyelitis. The Global Vaccine Data Network cohort study included 99 million vaccinated people from 10 sites across eight countries.
28 maj 2021 · Following the first injection, 63% had local adverse events (AEs): injection site pain (51%), swelling (8%), redness (6%), and itching (4%). 34% reported systemic AEs including myalgia (32%), fatigue (18%), headache (12%), joint pain (5%), and chills (5%). 199 (15%) had received the second (booster) vaccination. 76% reported local AEs including ...
The most common side effects for all these vaccines are mild and may include pain, swelling, or redness where the vaccine was given. Before getting any vaccine, talk with a doctor or pharmacist about your health history, including past illnesses and treatments, as well as any allergies.
19 lis 2021 · The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits.
2 sie 2023 · A to D, Risk ratios (RRs) and 95% CIs for acute myocardial infarction (A), pulmonary embolism (B), myocarditis or pericarditis (C), and hemorrhagic stroke (D) were estimated using generalized linear models with a binominal distribution and log link function.
